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Abstract Cellular synthesis of neuroendocrine peptides requires
prohormone convertases (PCs). In order to determine the role of
PC2 for gastrin synthesis, we examined antral extracts from
mice lacking PC2 or its chaperone, 7B2. The overall concentra-
tions of precursors and K-amidated gastrins were similar in all
mice. Chromatography, however, revealed that while the K53^K54
site was almost fully cleaved in controls and half cleaved in PC2
null mice, only 23% was cleaved in 7B2 null mice. The results
show that PC2 and 7B2 both are required for synthesis of the
main form of gastrin (gastrin-17), and that 7B2 exhibits effects
beyond PC2-mediated cleavages. ß 2002 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
The gastrointestinal hormone, gastrin, regulates gastric acid
secretion and mucosal cell growth (for reviews, see refs. [1,2]).
Most gastrin is synthesized in antral G-cells, where progastrin
through multiple modi¢cations matures to bioactive carboxy-
amidated gastrins of di¡erent chain lengths (Fig. 1). Mamma-
lian progastrins harbor three dibasic cleavage sites (R36^R37,
K53^K54, and R73^R74) of which cleavage of the K^K site
determines the amount of gastrin-17 produced relative to
that of gastrin-34. In most mammals, more than 90% of the
G-cell gastrin is the heptadecapeptide amide, gastrin-17, a few
percent is gastrin-34, and the rest are traces of either the long
gastrin-71 or the shorter gastrin-14 and gastrin-6 peptides
[3^8]. Outside the antrum, the gastrin gene is expressed at
low levels in speci¢c intestinal and pancreatic endocrine cells,
in pituitary cortico- and melanotrophs, in hypothalamic neu-
rons, in spermatocytes and in various adenocarcinomas
[9^18]. The extra-antral level of expression is, however, low
compared to that of the antrum, and in addition the process-
ing is cell-type speci¢c. For instance, there is no cleavage of
the K^K site in either ileal TG-cells or pituitary corticotrophs,
which accordingly synthesize only gastrin-34 and no gastrin-
17 [19,20].
The elaborate posttranslational maturation of progastrin
requires several processing enzymes (Fig. 1). While the precise
involvement of tyrosyl sulfotransferases, carboxypeptidase E
and the amidation enzyme complex (peptidyl-glycine K-ami-
dating monooxygenase (PAM)) by now is well established
[21^23], the roles of prohormone convertases (PCs) 1, 2 and
other PCs in progastrin processing remains to be de¢ned.
Mammals express seven PCs of which PC1 and PC2 are as-
sumed to be responsible for most of the endoproteolytic pro-
cessing of neuroendocrine proproteins (for reviews, see refs.
[24^26]). Accordingly, PC1 and PC2 have been demonstrated
immunochemically in human and rat G-cells [27,28]. The PC
cleavages typically occur at dibasic sites. Of the three such
sites in progastrin, cleavage of the C-terminal R73^R74 deter-
mines the availability of the glycine-extended precursor for K-
amidation (Fig. 1), and hence for gastrin peptides to become
bioactive. On the other hand, processing of the two N-termi-
nal sites (R36^R37 and K53^K54) determines the length of the
N-terminal extensions, and hence whether the carboxyami-
dated fragments become either gastrin-34 or gastrin-17, the
two major gastrins in circulation.
In order to determine the role of PC2, we have now exam-
ined the antral G-cell processing of progastrin in PC2 and 7B2
null mice. 7B2 is a neuroendocrine protein, that acts as a
cellular binding protein necessary for PC2 activity [26]. An
attractive aspect of the study is that progastrin, with its
well-de¢ned double-R and double-K sites, may be an instruc-
tive substrate for examination of the relative roles of PC1 and
PC2 in hormone synthesis.
2. Materials and methods
2.1. Mice
Both PC2 and 7B2 knockout (3/3) and corresponding wild-type
(+/+) mice were generated by intercrossing heterozygotes and geno-
typing the o¡spring [29,30]. The PC2 knockouts (3/3) [29] and cor-
responding controls (both C57BL/6J:Sv129 (50:50 mix) mice) were
purchased from The Jackson Laboratory (Bar Harbor, ME, USA),
whereas the 7B2 knockouts (3/3) [30] and controls (both Sv129 mice)
were generated in LSUMC (New Orleans, LA, USA). The mice were
housed on a 12 h light^dark cycle and freely fed. All experiments were
approved by the Animal Ethics committees of the local institutions.
2.2. Tissue isolation and extraction
Mice between 2 and 6 months of age in groups of ¢ve or eight were
sacri¢ced by CO2 inhalation, and stomach tissue was rapidly dissected
and frozen on dry ice. The tissue was gently cleaned in phosphate-
bu¡ered saline on ice before freezing. Tissue extracts for radioimmu-
noassay (RIA) were prepared as previously described [31]. Brie£y,
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frozen tissues were boiled in water (1 ml/mg) for 20 min, homogenized
(polytron) and centrifuged for 30 min at 10 000 rpm. The supernatants
were withdrawn and the pellets re-extracted in 0.5 M CH3COOH
(1 ml/mg), rehomogenized, incubated at room temperature for
30 min and centrifuged. The neutral water and acid supernatants
were stored at 320‡C until RIA analysis.
2.3. Chromatography
1 or 2 ml of extracts were applied to Sephadex G-50 super¢ne
columns (10U1000 mm), which were eluted at 4‡C with 0.02 M bar-
bital bu¡er, pH 8.4, containing 0.1% bovine serum albumin. Fractions
of 1.0 ml were collected at a rate of 4.0 ml/h. The columns were
calibrated with [125I]albumin (void volume), gastrin-34 and gastrin-
17, and with 22NaCl (total volume). The eluted fractions were assayed
with a sequence-speci¢c RIA using antibody no. 2604 as described
below. The percentages of K-amidated gastrin were calculated by
planimetry. Four di¡erent extracts from each of the four groups of
mice (PC2 knockout, 7B2 knockout and corresponding controls) were
subjected to gel chromatography.
2.4. RIAs
A library of sequence-speci¢c antibodies against progastrin was
used to measure the di¡erent forms of gastrin and its processing
intermediates (Fig. 1). The sum of carboxyamidated, bioactive gastrin
was measured using the gastrin-speci¢c antiserum no. 2604, with
[125I]gastrin-17 as tracer and gastrin-17 as standard [32]. Antibody
no. 2604 binds all the carboxyamidated forms of gastrin (except gas-
trin-6) with equimolar a⁄nity irrespective of size and sulfation. The
crossreactivity with homologous cholecystokinin peptides is negligible
[32]. Non-sulfated carboxyamidated gastrins were measured in parallel
using antibody no. 2605 [33]. Glycine-extended processing intermedi-
ates of progastrin were measured using antiserum no. 3208 with
[125I]glycine-extended gastrin-17 as tracer and glycine-extended gas-
trin-17 as standard. Glycine^arginine-extended intermediate precur-
sors were measured using antiserum no. 3208 following enzymatic
pretreatment with only carboxypeptidase B (CPB). To measure all
precursor forms of gastrin, samples were pretreated with both trypsin
and CPB followed by RIA with antiserum no. 3208, as described
previously [34]. CPB mimics the e¡ect of carboxypeptidase E, while
trypsin mimics the e¡ects of PCs.
3. Results
As shown in Tables 1 and 2, the concentrations of progas-
trin, its main categories of processing intermediates, and its
functional end product, the carboxy- or K-amidated gastrins,
were similar in the antral extracts of knockout mice and their
corresponding wild-type controls. The degree of tyrosyl O-
sulfation of the gastrins was also similar in knockout and
wild-type mice. These measurements would seem to indicate,
that PC1, tyrosyl-sulfotransferases, carboxypeptidase E and
PAM act independently of PC2 and 7B2 in antral G-cells.
Gel chromatography, however, displayed major processing
abnormalities in the 7B2 and PC2 knockout mice. As shown
in Fig. 2 and Table 3, gastrin-34 constituted by far most of the
carboxyamidated gastrin in the antrum of 7B2 knockout mice,
PC2 knockout antra contained equal amounts of gastrin-34
and gastrin-17 and the antral gastrin in the wild-type mice was
mainly gastrin-17, the predominant antral gastrin of all mam-
mals. Hence, the chromatography shows that the K53^K54
cleavage site of progastrin that normally is almost completely
processed (i.e. s 90%) is only partly cleaved (V50%) in the
absence of PC2. But in the absence of 7B2, only 23% of the
double-K sites are processed.
Tables 1 and 2 also reveal di¡erences between the progas-
trin concentrations, for instance, of the two groups of wild-
type controls. Presumably, the di¡erences re£ect that di¡erent
strains of mice were examined. As mentioned above, the PC2
study used C57BL/6J:Sv129 (50:50 mix) mice, and the 7B2
study Sv129 mice. Moreover, the mice in the 7B2 study and its
controls were three weeks younger than those in the PC2
study due to the high mortality of 7B2 null mice [30].
4. Discussion
The relative contributions of the various convertases to bio-
logically relevant precursor cleavages is only now beginning to
be elucidated. One of the important ¢ndings of the present
study is that PC2-mediated cleavage occurs at the K53^K54
site of progastrin. Cleavage at this site is necessary for syn-
thesis of the major functional product of progastrin, the car-
boxyamidated gastrin-17 peptide, which is known to be re-
leased from antroduodenal G-cells that produce most of the
gastrin in mammals. The present in vivo data support the
earlier observation from our laboratory that pituitary cortico-
trophs, which contain only PC1, cannot process the K53^K54
site [11,19]. The later study of Sawada et al. [35] also supports
this notion. They found that PC2 but not PC1 can accomplish
cleavage of this site in transfected AtT-20 cells [35]. Similarly
to progastrin, proopiomelanocortin (POMC) also contains a
K^K site within L-endorphin which remains unprocessed in
AtT-20 cells, but can be processed upon cotransfection with
PC2 [36,37]. However, cleavage of the K^K site within pro-
enkephalin is apparently largely mediated by PC1, since it is
e⁄ciently cleaved within AtT-20 cells [38]. Examination of the
primary sequences of the three precursors (progastrin, POMC,
and proenkephalin) reveals extensive di¡erences in the vicinity
of the K^K site, which could account for the di¡erential abil-
ity of PC1 to recognize these types of processing sites within
di¡erent contexts.
Since half of the K^K sites within progastrin can be cleaved
in the absence of PC2, other convertases are also likely to
participate in this cleavage in vivo. Potential candidates for
this activity include PC1 and PC5, both expressed in G-cells
([27,28] and Friis-Hansen, unpublished data). The cleavage
speci¢city of PC5 is not known at present. As mentioned
above, PC1 is apparently unable to perform this particular
cleavage since the site remains uncleaved within AtT-20 cells
[19,35].
It is interesting to note that the cleavage pro¢les of progas-
trin-derived peptides di¡er between the PC2 and 7B2 null
mice. Since 7B2 is thought to represent a binding partner
for PC2, which is absolutely required for the production of
Table 1
Antral progastrin products in PC2 null and corresponding wild-type mice (pmol/g tissue (mean þ S.E.M.) n = 8)
PC2 null Wild-type
Progastrin 4.2 þ 1.3 2.8 þ 0.7
Gastrin^Gly-Arg-(Arg) 0.0 þ 0.0 0.1 þ 0.0
Gastrin^Gly 1.3 þ 0.3 1.1 þ 0.3
Gastrin (K-amidated) 150.0 þ 28.0 130.1 þ 27.0
Gastrin (K-amidated and non-sulfated) 43.2 þ 8.6 34.0 þ 8.5
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active enzyme [39], one might expect that the absence of either
protein would yield a similar PC2-less processing pro¢le. The
data of this study indicate that cleavage of the two R^R sites
(at positions 36^37 and 73^74) occurs without interruption in
the two null animals. Therefore, cleavage at these sites is
presumed to be mediated by PC1 [26,40]. However, cleavage
of the K^K site mentioned above is signi¢cantly reduced in
the 7B2 null animals as compared to the PC2 null animals.
This unexpected result may indicate a role for 7B2 which
extends beyond its function as an activating protein for
proPC2. Such a role is hinted at by previous studies showing
that 7B2 null animals hypersecrete ACTH from the intermedi-
ate lobe of the pituitary, while PC2 null animals do not ([30]
and Lindberg, unpublished results). This role is unlikely to
represent binding to other convertases, as no convertase other
than PC2 was able to interact with 7B2 in co-immunoprecip-
itation experiments [40]. Proenkephalin is apparently similarly
processed in PC2 and 7B2 null animals [30,41] ; however,
preliminary results indicate that processing of POMC di¡ers
somewhat between PC2 and 7B2 nulls (Laurent and Lindberg,
unpublished results). Proglucagon processing in both null
models has been studied using pulse-chase analysis [30,42]
Fig. 1. Diagrammatic presentation of the co- and posttranslational modi¢cation of preprogastrin in the stomach. Activation of the gastrin ami-
dation site (^Phe-Gly-Arg-Arg^) occurs via a series of carboxy-terminal cleavages and modi¢cations. Endoproteolytic cleavage by PCs produces
the carboxypeptidase E substrate (^Phe-Gly-Arg). Carboxypeptidase E then acts in secretory granules to remove the C-terminal arginine residue
yielding glycine-extended gastrin (^Phe-Gly). Carboxyamidation of glycine-extended gastrin by K-amidating monooxygenase results in the pro-
duction of bioactive gastrin (^Phe-NH2). Concomitant N-terminal cleavage by PCs produces bioactive gastrins of varying size (e.g. gastrin-34
and gastrin-17). A library of sequence-speci¢c antibodies was used in combination with in vitro protease treatments to measure bioactive gas-
trin and various precursor peptides, as described in the text.
Table 2
Antral progastrin products in 7B2 null and corresponding wild-type mice (pmol/g tissue (mean þ S.E.M.) n = 5)
7B2 null Wild-type
Progastrin 7.0 þ 1.4 6.8 þ 2.8
Gastrin^Gly-Arg-(Arg) 0.0 þ 0.0 0.3 þ 0.1
Gastrin^Gly 1.4 þ 0.4 1.8 þ 0.6
Gastrin (K-amidated) 120.0 þ 41.0 160.0 þ 48.2
Gastrin (K-amidated and non-sulfated) 36.1 þ 8.8 57.1 þ 24.0
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and has been shown to be slightly more extensive in the PC2
null than in the 7B2 null mice, results opposite to those pre-
sented here. Thus, the contribution of supplementary roles for
7B2 (i.e. beyond those of assisting PC2) to overall processing
appears to vary by the structure of the precursor to be pro-
cessed, and will require additional investigation. Given the
recent identi¢cation of a binding partner for PC1, proSAAS
[43], the di¡erential contributions of convertase binding pro-
teins to precursor processing is likely to represent a fruitful
area for further study.
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